Hangzhou LifeReal Biotechnology
PrivateLast Round
Series B
May 1, 2022
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hangzhou LifeReal Biotechnology is a medical supplies company that develops and produces life science and clinical diagnostic products.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou LifeReal Biotechnology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hangzhou LifeReal Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Series A Extension | Jul 16, 2020 | ||||
| Series A | May 31, 2019 | ||||
| Angel | Apr 1, 2017 |
Hangzhou LifeReal Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zheshang Venture Capital | Series B, Series A Extension |
| YuanBio Venture Capital | Series B, Angel |
| GF Venture Capital | Series B |
| Huagai Capital | Series B, Series A |
| China Growth Capital | Series B, Series A Extension |
| Ennovation Ventures | Series B, Angel |
| 广发乾和投资有限公司 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 95% MoM.
- May 15, 2026
Monthly visitors grew 191% MoM, reaching 704.
Hangzhou LifeReal Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou LifeReal Biotechnology's valuation, stock price, and market status.